Cargando…

Selective retina therapy (SRT) in patients with therapy refractory persistent acute central serous chorioretinopathy (CSC): 3 months functional and morphological results

PURPOSE: Central serous chorioretinopathy (CSC) is a disease presenting with detachment of the neurosensory retina and characteristic focal leakage on fluorescein angiography. The spontaneous remission rate is 84% within 6 months. In this study, the efficacy of selective retina therapy (SRT) was exa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Büttner, Maximilian, Luger, Benjamin, Abou Moulig, Wasim, Junker, Bernd, Framme, Carsten, Jacobsen, Christina, Knoll, Katharina, Pielen, Amelie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Retinal Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166675/ https://www.ncbi.nlm.nih.gov/pubmed/33205239 http://dx.doi.org/10.1007/s00417-020-04999-9

Ejemplares similares

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathy
por: Schworm, Benedikt, et al.
Publicado: (2021)

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
por: van Rijssen, Thomas J., et al.
Publicado: (2018)

Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser
por: Gawęcki, Maciej, et al.
Publicado: (2017)

Algorithms for optoacoustically controlled selective retina therapy (SRT)
por: Seifert, Eric, et al.
Publicado: (2021)

Fundus autofluorescence abnormalities can predict fluorescein angiography abnormalities in patients with chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2023)

Optical coherence tomography angiography–guided vs indocyanine green angiography–guided half-dose photodynamic therapy for acute central serous chorioretinopathy: 6-month randomized trial results
por: Li, Siying, et al.
Publicado: (2023)

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3
por: Feenstra, Helena M. A., et al.
Publicado: (2022)

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
por: Jaissle, Gesine B., et al.
Publicado: (2010)

Importance of continuous treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration—12-month post hoc analysis of the PERSEUS real-world evidence study
por: Wachtlin, Joachim, et al.
Publicado: (2020)

PERSEUS 24-month analysis: a prospective non-interventional study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Germany in patients with neovascular age-related macular degeneration
por: Eter, Nicole, et al.
Publicado: (2021)

The extracellular matrix complexity of idiopathic epiretinal membranes and the bilaminar arrangement of the associated internal limiting membrane in the posterior retina
por: Altera, Annalisa, et al.
Publicado: (2021)

Delayed follow-up of medical retina patients due to COVID-19: impact on disease activity and visual acuity
por: Stone, Lydia G., et al.
Publicado: (2021)

Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect”
por: Borrelli, Enrico, et al.
Publicado: (2020)

Treatment contentment and preference of patients undergoing intravitreal anti-VEGF therapy
por: Kellner, Ulrich, et al.
Publicado: (2021)

Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
por: Fassnacht-Riederle, Heidi, et al.
Publicado: (2014)

Impact of intravitreal injection therapy on contrast sensitivity in patients with nAMD and DME
por: Dieke, Sebastian, et al.
Publicado: (2023)

Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration
por: Hörster, Robert, et al.
Publicado: (2010)

Vitrectomy with and without encircling band for pseudophakic retinal detachment with inferior breaks: VIPER Study Report No. 3
por: Baumgarten, Sabine, et al.
Publicado: (2018)

Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy
por: Mikhail, Michael, et al.
Publicado: (2018)

Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
por: Pellegrini, Marco, et al.
Publicado: (2020)

Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland
por: Zirpel, Johanna J., et al.
Publicado: (2021)

Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema
por: Kida, Teruyo, et al.
Publicado: (2021)

Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
por: de Salles, Manuel Casselholm, et al.
Publicado: (2021)

The detrimental effects of delayed intravitreal anti-VEGF therapy for treating retinal pathology: lessons from a forced test-case
por: Navarrete, Ana, et al.
Publicado: (2022)

Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
por: Liu, Siyin, et al.
Publicado: (2022)

Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study
por: Gao, Tingting, et al.
Publicado: (2018)

Analysis of imaging biomarkers and retinal nerve fiber layer thickness in RPGR-associated retinitis pigmentosa
por: Birtel, Theresa H., et al.
Publicado: (2021)

One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy
por: Yamakiri, Keita, et al.
Publicado: (2008)

Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial
por: Hoerauf, Hans, et al.
Publicado: (2011)

Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion
por: Fortunato, Pina, et al.
Publicado: (2009)

The effect of a preoperative subconjuntival injection of dexamethasone on blood–retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial
por: Bali, Ernesto, et al.
Publicado: (2010)

Pattern recognition can detect subtle field defects in eyes of HIV individuals without retinitis under HAART
por: Goldbaum, Michael H., et al.
Publicado: (2010)

Near-infrared reflectance imaging of neovascular age-related macular degeneration
por: Theelen, Thomas, et al.
Publicado: (2009)

Pars plana vitrectomy for the repair of primary, inferior rhegmatogenous retinal detachment associated to inferior breaks. A comparison of a 25-gauge versus a 20-gauge system
por: dell’Omo, Roberto, et al.
Publicado: (2012)

Posterior vitreous detachment following intravitreal drug injection
por: Geck, Ulrich, et al.
Publicado: (2013)

FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity
por: Monés, Jordi, et al.
Publicado: (2012)

Long-term intraocular pressure changes after vitrectomy for epiretinal membrane and macular hole
por: Fujikawa, Masato, et al.
Publicado: (2013)

The price for reduced light toxicity: Do endoilluminator spectral filters decrease color contrast during Brilliant Blue G–assisted chromovitrectomy?
por: Henrich, Paul B., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5rof98fjidj7vvjfdddin323kk